BBC presenter taken to hospital in ambulance after ‘real wake up call' working at Wimbledon and putting off medical care
The journalist took to Instagram to lift the lid on a difficult few weeks for him following an admission to hospital in the middle of the SW19 tournament.
5
5
5
5
He did not provide details on what exactly the issue was, but said it had escalated after he had put off going to see a medical professional.
Qasa said: "I can't say the last few weeks have been easy…
"Ever since the middle of Wimbledon I've been battling my body with a health issue.
"I put off getting proper medical care because I just did not want to miss The Championships (error). Eventually it became too much & escalated.
"Thankfully the NHS have been brilliant in giving me the care I needed."
He described the incident as a "real wake up call" and warned his followers to not put off seeking help if needed as it "will completely knock you for six".
Qasa added: "Respect your body and its limitations. We only have one.
"Grateful to my family for helping me through a difficult period & now the road to recovery."
Qasa shared pictures of his time at the hospital and during his journey to hospital on his post.
Originally from Birmingham, Qasa joined the BBC in 2010 working for local radio before going on to win a Frank Gillard Award for his coverage for Radio 4 about Stoke-on-Trent's illegal sex trade.
He made his BBC1 debut in 2016 before directing a film for the broadcaster in 2017.
Qasa was named Radio Presenter of the Year in 2020 in the Asian Media Awards for his work on BBC Asian Network.
He covered The Boat Race and 2022 Commonwealth Games in his hometown of Birmingham before taking on the role as BBC's flagship daily tennis highlights presenter for Wimbledon in 2023.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Telegraph
3 minutes ago
- Telegraph
‘Cosmetic cowboys' to be banned from carrying out Brazilian butt lifts
'Cosmetic cowboys' will be banned from performing high-risk procedures under new Government plans. The crackdown follows incidents in which patients have been maimed, and deaths linked to poor care and rogue operators. Under the measures, only qualified healthcare professionals such as doctors and nurses will be able to deliver procedures such as Brazilian butt lifts. These will only be able to be carried out by providers regulated by the health regulator, the Care Quality Commission. Clinics administering Botox and fillers will have to meet new standards and be licenced by councils. Under-18s will be banned from high risk procedures, such as injectables, amid concerns that children needed to be protected from 'dangerous beauty trends on social media'. Health officials said the steps aimed to protect the public from 'rogue operators' with no medical training, who often provided 'invasive' procedures in homes, hotels and pop-up clinics. The move would also reduce the cost imposed upon the NHS to fix botched procedures, the Department of Health and Social Care said. Karin Smyth, the health minister, said: 'The cosmetics industry has been plagued by a wild west of dodgy practitioners and procedures. There are countless horror stories of 'cosmetic cowboys' causing serious, catastrophic damage. 'This Government is taking action to protect those seeking treatments, support honest and competent practitioners, and root out the cowboys as part of our Plan for Change. 'This isn't about stopping anyone from getting treatments – it's about preventing rogue operators from exploiting people at the expense of their safety and keeping people safe. We're giving them peace of mind and reducing the cost to the NHS of fixing botched procedures.' Those who break the rules on high-risk procedures could face sanctions from the watchdog and financial penalties. The department said it would launch a consultation next year, seeking views on the range of procedures that should be covered by the new restrictions. Last month, the Chartered Trading Standards Institute warned that fat injections, Brazilian butt lifts, Botox and fillers are being offered by untrained people in places such as public toilets. There have also been concerns about rising numbers of people poisoned by fake Botox, leaving consumers struggling with breathing and swallowing problems, and slurred speech, after suffering from botulism. Millie Kendall, the chief executive of the British Beauty Council, said: 'Any measures that increase protection for the general public and professionalise the industry will help instil confidence, as well as helping to prevent the normalisation of horror stories that have become synonymous with our sector.' Ashton Collins, the director of Save Face, a register of accredited practitioners, said: 'I am delighted that the Government has recognised the significant and potentially fatal risks posed by highly dangerous procedures like liquid Brazilian butt lifts and has made it a priority to implement restrictions to protect public safety. 'I have seen first-hand the devastating impact these procedures can have on the lives of victims and their families, none more so than the family of Alice Webb.' Webb died last year, aged 33, after suffering complications from having a non-surgical Brazilian butt lift, which involved cosmetic fluid being injected into her buttocks. The mother-of-five worked in the beauty industry and lived in Gloucestershire.
The Independent
32 minutes ago
- The Independent
FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths
U.S. health regulators are warning doctors and patients about safety issues with two separate Boston Scientific heart devices recently linked to injuries and deaths. The Food and Drug Administration issued two alerts Wednesday about electrical problems tied to the company's heart-zapping defibrillator systems and a separate issue with a heart implant used to reduce stroke risk. The agency said the company's Endotak Reliance defibrillator wires can become calcified, leading to failures in delivering life-saving shocks to the heart, according to the FDA. Defibrillators are surgically placed in the upper chest, where they monitor irregular heartbeats and use electrical shocks to jolt the heart back to normal. As of July 24, Boston Scientific has reported 386 serious injuries and 16 deaths associated with this issue, the agency said. Ten of the deaths were judged to be due to the device failing to function properly, the company said in an email. Four were linked to attempts to surgically remove the devices from patients and two others were deemed unrelated to the implants. Boston Scientific's wires were distributed between 2002 and 2021 and are no longer available, the company noted in its letter to doctors. Some patients will need to have the devices replaced, though physicians should weigh the risks of the removal procedure. In a separate notice, the FDA said Boston Scientific recently updated instructions for implanting its Watchman device, which closes a portion of the heart's left atrium to reduce the risk of stroke. In a letter to physicians, the company noted that there is an increased risk of blockages in the bloodstream depending on the level of anesthesia for patients undergoing the initial implantation procedure. Watchman is an alternative to long-term treatment with blood thinners for patients at increased risk of stroke. As of July 30, the company has reported 120 serious injuries and 17 deaths related to the issue, the FDA said. A company investigation concluded that the safety issue 'is not associated with the design or manufacture of any component of the Watchman system. Heart devices, including defibrillators and other implants, are Boston Scientific's largest business, making up two-thirds of its $5 billion in revenue for the most recent quarter. Shares of Boston Scientific Corp. fell nearly 1.8 percent Wednesday to close at $102.95 in trading. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
The Sun
33 minutes ago
- The Sun
Man, 45, died ‘taking de-worming drug for animals after seeing fake claims online it could cure cancer'
A MAN died after taking a de-worming drug for animals as he believed it would cure cancer, an inquest heard. Lee Redpath, 45, was rushed to hospital with signs of liver failure after dosing himself with an anti-parasitic drug called fenbendazole across a three-week period. 7 7 7 He tragically died in Addenbrooke's Hospital, in Cambridge, on April 29. Lee had ordered the drug, believing it to be safe, from a supplier in Ukraine. The 45-year-old saw fake social media posts which claimed fenbendazole could be a cancer cure - despite it being banned for human use. It's designed to be used against a number of gastrointestinal parasites in animals including giardia, roundworms, hookworms, whipworms, tapeworms and pinworms. However, even A-list celebrities have promoted the drug for humans, including actor Mel Gibson. He told Joe Rogan earlier this year how three of his friends were cured of stage four cancer after taking it with the anti-parasitic Ivermectin. The inquest, held in Lawrence Court, Huntingdon, Cambs, heard how Lee believed the de-wormer could prevent cancer. His long-term partner Lauren Laul gave evidence at the inquest. She told how her boyfriend believed it was safe to use and popular in the States. 'He saw it online, thought it was safe, people in America are using it," said Lauren. 'He didn't have medical assistance taking it so I think some sort of warning should be made. 'I am seeing it advertised online and people can get it themselves like Lee did and unknowingly be killing themselves because they didn't have all the information.' Lauren also suggested Lee may have been taking them for as long as two years before his death. Dr Gwilym Webb, a consultant hepatologist at Addenbrooke's warned fenbendazole had 'no proven benefit for preventing or treating cancer in humans.' 7 7 7 He told the inquest Lee was not eligible for a liver transplant due to alcohol misuse in the three months before. But a post-mortem concluded Lee's liver failure was due to the fenbendazole. Assistant coroner for Cambridgeshire and Peterborough, Caroline Jones, concluded Lee died of liver and renal failure due to fenbendazole induced liver injury on a background of alcohol related cirrhosis. 'I was satisfied as to the toxic effects of fenbendazole and that it was this that was the primary cause of the injury," she told the inquest. 'It is a potent anti-worming treatment which was taken at far higher relative doses than had ever been envisaged and over a far longer time scale. 'During his admission he advised doctors that he had been taking the drug fenbendazole, which he purchased online from a supplier in the Ukraine after seeing videos about its supposed anti-cancer properties. 'It was thought likely fenbendazole was the primary cause of the acute injury. Lee's conditions deteriorated despite treatment but he was not a candidate for transplant. 'He improved briefly but on April 27 his condition worsened, it was recognised Lee's organs were failing and he passed away at 6.06 pm on April 29. 'While Lee may have taken fenbendazole with good intentions to improve his health, it constituted a deliberate act with the unintended consequence of his death.' Lauren urged the coroner to write a prevention of future deaths report, but Miss Jones denied her request. The coroner said there was not "sufficient evidence", although she was "concerned" about people buying the drug online. Lee's death was recorded as misadventure. 7
